The neurotoxic effect of anesthetics on the developing brain is a long-standing clinical issue. Numerous animal and human studies have demonstrated the neurotoxicity of anesthetics on the developing brain \[[@B1][@B2][@B3][@B4]\]. In the present issue of the *Korean Journal of Anesthesiology* (*KJA*), we discuss the influence of age and sex on the long-term behavioral consequences of multiple exposures during the fetal period. In the present issue of *KJA*, Chung et al. \[[@B5]\] showed that multiple sevoflurane exposure during the second trimester of pregnancy can affect learning and memory function in young mice, especially in female mice.

The general anesthesia compared to spinal anesthesia (GAS) study \[[@B6]\], a recent international multicenter, randomized controlled trial, demonstrated no evidence of the increased risk of an adverse neurodevelopmental effect of a short period of sevoflurane anesthesia in 2-year-old children. However, we still cannot rule out the possibility of certain harmful effects of anesthesia on the developing brain. Accordingly, the U.S. Food and Drug Administration (FDA) issued a warning that the repeated or lengthy use of anesthesia in children less than 3 years of age or during the third trimester of pregnancy may affect the child\'s brain development (<https://www.fda.gov/Drugs/DrugSafety/ucm532356.htm>). They also updated their warnings to state that these drugs may negatively affect brain development in children less than 3 years of age (<https://www.fda.gov/Drugs/DrugSafety/ucm554634.htm>). Moreover, Strategies for Mitigation of Anesthesia-Related Neurotoxicity in Tots (SmartTots), established by the FDA and the International Anesthesia Research Society, continues to update its regulations on the safe use of anesthetics and sedatives in children, based on the most recent knowledge (<http://smarttots.org/>).

Given the lack of clinical and experimental evidence, apart from the putative negative effects on children, it is difficult to determine whether anesthetics may affect neurodevelopment of the fetal brain. Many factors, including microbial composition, immune activation, metabolism, and neural pathways, can cause neurodevelopmental disabilities \[[@B7]\]. Among these, age, the number of exposures, and sex were regarded as the most influential factors. Thus, current animal studies tend to focus on the age of exposure \[[@B8][@B9][@B10]\]. Lee et al. \[[@B11]\] also previously revealed that neither single nor multiple exposures to sevoflurane during fetal development affected long-term behavioral dysfunction. In their article in the present issue, Chung et al. \[[@B5]\] reported an interesting finding that sevoflurane exposure only affected the learning and memory functions in female mice. This finding suggests differences between the sexes at physiological and molecular levels, which may warrant further detailed experimental studies.
